ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
PiesEyes
|
621 |
193K |
6 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
621
|
193K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
PiesEyes
|
621 |
193K |
25 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
621
|
193K
|
25
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
PiesEyes
|
621 |
193K |
6 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
621
|
193K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
PiesEyes
|
176 |
50K |
9 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
176
|
50K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
PiesEyes
|
423 |
146K |
1 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
423
|
146K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing
|
|
PiesEyes
|
111 |
45K |
1 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
111
|
45K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Appoints Chief Medical Officer
|
|
PiesEyes
|
15 |
4.5K |
14 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
15
|
4.5K
|
14
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Closes SPP Oversubscribed
|
|
PiesEyes
|
146 |
42K |
6 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
146
|
42K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: SPP and Options Prospectus
|
|
PiesEyes
|
115 |
46K |
6 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
115
|
46K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: DMX-200 CLARITY COVID-19 Study Approval in India
|
|
PiesEyes
|
43 |
14K |
13 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
43
|
14K
|
13
|
|
ASX - By Stock
|
DXB |
Re:
Ann: SPP and Options Prospectus
|
|
PiesEyes
|
115 |
46K |
6 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
115
|
46K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: DMX-200 COVID-19 Study Opens More Sites in Europe and UK
|
|
PiesEyes
|
50 |
13K |
9 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
50
|
13K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
Oct 2
|
|
PiesEyes
|
49 |
16K |
7 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
49
|
16K
|
7
|
|
ASX - By Stock
|
VML |
Re:
VML Chart Thread
|
|
PiesEyes
|
1.7K |
627K |
1 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
1.7K
|
627K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
|
|
PiesEyes
|
623 |
253K |
16 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
623
|
253K
|
16
|
|
ASX - By Stock
|
VML |
Re:
VML Chart Thread
|
|
PiesEyes
|
1.7K |
627K |
2 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
1.7K
|
627K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
PiesEyes
|
356 |
126K |
14 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
356
|
126K
|
14
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
PiesEyes
|
356 |
126K |
5 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
356
|
126K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
PiesEyes
|
356 |
126K |
0 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
356
|
126K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
General Discussion
|
|
PiesEyes
|
134 |
38K |
0 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
134
|
38K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
General Discussion
|
|
PiesEyes
|
134 |
38K |
15 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
134
|
38K
|
15
|
|
ASX - By Stock
|
DXB |
Re:
Take a deep breath
|
|
PiesEyes
|
44 |
17K |
10 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
44
|
17K
|
10
|
|
ASX - By Stock
|
DXB Biotech |
Re:
Valuation post positive results
|
|
PiesEyes
|
195 |
95K |
24 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
195
|
95K
|
24
|
|
ASX - By Stock
|
DXB Biotech |
Re:
Valuation post positive results
|
|
PiesEyes
|
195 |
95K |
9 |
22/08/20 |
22/08/20 |
ASX - By Stock
|
195
|
95K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Positive Top-Line Results in FSGS Phase 2a Clinical Study
|
|
PiesEyes
|
286 |
87K |
0 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
286
|
87K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Positive Top-Line Results in FSGS Phase 2a Clinical Study
|
|
PiesEyes
|
286 |
87K |
24 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
286
|
87K
|
24
|
|
ASX - By Stock
|
DXB |
Re:
Count down to release of results
|
|
PiesEyes
|
70 |
20K |
21 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
70
|
20K
|
21
|
|
ASX - By Stock
|
DXB |
Re:
CR @ 36c
|
|
PiesEyes
|
98 |
32K |
2 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
98
|
32K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $5.8m Placement
|
|
PiesEyes
|
107 |
32K |
10 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
107
|
32K
|
10
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $5.8m Placement
|
|
PiesEyes
|
107 |
32K |
8 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
107
|
32K
|
8
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $5.8m Placement
|
|
PiesEyes
|
107 |
32K |
11 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
107
|
32K
|
11
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Last Patient Completes Dosing in FSGS Phase 2 Clinical Study
|
|
PiesEyes
|
41 |
12K |
7 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
41
|
12K
|
7
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
1 |
14/06/20 |
14/06/20 |
ASX - By Stock
|
247
|
75K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
21 |
14/06/20 |
14/06/20 |
ASX - By Stock
|
247
|
75K
|
21
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
18 |
13/06/20 |
13/06/20 |
ASX - By Stock
|
247
|
75K
|
18
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
34 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
247
|
75K
|
34
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
11 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
247
|
75K
|
11
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
23 |
07/06/20 |
07/06/20 |
ASX - By Stock
|
247
|
75K
|
23
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
6 |
06/06/20 |
06/06/20 |
ASX - By Stock
|
247
|
75K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
14 |
06/06/20 |
06/06/20 |
ASX - By Stock
|
247
|
75K
|
14
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
15 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
247
|
75K
|
15
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
3 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
247
|
75K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Global REMAP-CAP Platform Trial Protocol To Include DMX-200
|
|
PiesEyes
|
247 |
75K |
10 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
247
|
75K
|
10
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
PiesEyes
|
149 |
48K |
4 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
149
|
48K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
PiesEyes
|
149 |
48K |
2 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
149
|
48K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Is biotech Dimerix the next billion-dollar Opthea?
|
|
PiesEyes
|
91 |
25K |
9 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
91
|
25K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
"Dimerix is on a golden run"
|
|
PiesEyes
|
160 |
43K |
8 |
09/05/20 |
09/05/20 |
ASX - By Stock
|
160
|
43K
|
8
|
|
ASX - By Stock
|
DXB Biotech |
Re:
Onward to results
|
|
PiesEyes
|
97 |
31K |
1 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
97
|
31K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Half Year Report and Update
|
|
PiesEyes
|
108 |
707K |
3 |
25/02/20 |
25/02/20 |
ASX - By Stock
|
108
|
707K
|
3
|
|
ASX - By Stock
|
DXB Biotech |
Re:
Taylor's Initiation
|
|
PiesEyes
|
67 |
31K |
2 |
06/01/20 |
06/01/20 |
ASX - By Stock
|
67
|
31K
|
2
|
|